RNS Number : 0688V
  Phosphagenics Limited
  22 May 2008
   

    NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
    This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R (1).

 (1)  An issuer making a notification in respect of a transaction relating to
      the shares or debentures of the issuer should complete boxes 1 to 16, 23
      and 24.
 (2)  An issuer making a notification in respect of a derivative relating the
      shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23
      and 24. 
 (3)  An issuer making a notification in respect of options granted to a
      director/person discharging managerial responsibilities should complete
      boxes 1 to 3 and 17 to 24. 
 (4)  An issuer making a notification in respect of a financial instrument
      relating to the shares of the issuer (other than a debenture) should
      complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. 

    Please complete all relevant boxes should in block capital letters.

    1. Name of the issuer
    PHOSPHAGENICS LIMITED
    2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or
    (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or 
    (iii) both (i) and (ii)
    3. Name of director
    JOHN MILLS (Professor) **
    4. State whether notification relates to a person connected with a director named in 3 and identify the connected person
    The transaction / event relates to a purchase on 21 May 2008 of 74,000 ordinary fully paid Phosphagenics Limited shares made on-market
in the normal course of trading of the Australian Stock Exchange on behalf of the Portsea Superannuation Fund registered in the names of
Professor John Mills & Professor Suzanne Mary Crowe< Portsea Superannuation Fund>. A Fund in which Professor Mills is a beneficiary.
     5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a
non-beneficial interest
    *Refer to the text of 4 above
    6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares
    Ordinary Fully Paid Shares
    7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
    Professor John Mills & Professor Suzanne Mary Crowe:    164,667 ordinary shares ( unchanged)
    Professor John Mills & Professor Suzanne Mary Crowe < Portsea Superannuation Fund>: 212,000 ordinary shares as varied by the 74,000
purchased as noted in item 4 above)
    8 State the nature of the transaction
    *Purchase on-market as described in 4 above
    9. Number of shares, debentures or financial instruments relating to shares acquired
    *74,000 ordinary shares on behalf of the Portsea Superannuation Fund

    10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
    *0.0111 per cent (Total number of Issued Ordinary Shares: 663,542,406 shares)
    11. Number of shares, debentures or financial instruments relating to shares disposed
    *N/A
    12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 
    *N/A
    13. Price per share or value of transaction
    **A$0.135
    14. Date and place of transaction
    **21 Mar 2008 as traded in the normal course of trading of the official lists of the Australian Stock Exchange
    15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken
into account when calculating percentage)
    376,667 ordinary shares being 0.0567 per cent of total Issued ordinary shares
    16. Date issuer informed of transaction
    *Wednesday p.m. 21May 2008 after close of trading on official lists of ASX Limited. 
    If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

    17 Date of grant
    *N/A*
    18. Period during which or date on which it can be exercised
    N/A*
    19. Total amount paid (if any) for grant of the option
    N/A**
    20. Description of shares or debentures involved (class and number)
    N/A**

    21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
    N/A
    22. Total number of shares or debentures over which options held following notification
    N/A*
    23. Any additional information
    NIL
    24. Name of contact and telephone number for queries
    Mourice Garbutt, Company Secretary, Phosphagenics Limited + 613 9605 5917
    Name and signature of duly authorised officer of issuer responsible for making notification
    Mourice Garbutt, Company Secretary, Phosphagenics Limited
    
    Date of notification

    *22 May 2008*

    END 
This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
RDSSEAFSESASEEI

Phosphagen. (LSE:PSG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Phosphagen. 차트를 더 보려면 여기를 클릭.
Phosphagen. (LSE:PSG)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Phosphagen. 차트를 더 보려면 여기를 클릭.